𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study

✍ Scribed by Hernan, M. A.; Jick, S. S.; Olek, M. J.; Jick, H.

Book ID
111880748
Publisher
Lippincott Williams and Wilkins
Year
2004
Tongue
English
Weight
156 KB
Volume
63
Category
Article
ISSN
0028-3878

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunogenicity of a yeast-recombinant he
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children
✍ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.